HealthDay - TUESDAY, March 25 (HealthDay News) -- righteous consonance imaging (MRI) can help predict the risk of cancer commemoration in prostate cancer patients who are about to have glimmer therapy, a new U.S. study says.
More: - From the site
Name(required)
Mail (will not be published)(required)
Website
Notify me of followup comments via e-mail.